Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - ORBIMED ADVISORS LLC
Last Updated 
19-Sep-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

ORBIMED ADVISORS LLC: Declared Holdings
Company/RelationshipReportedShares  Ownership
Ambit Biosciences Corporation
Beneficial Owner (10% or more)
NasdaqGM:AMBI
(historical quotes, profile, other insiders)
23-May-131,476,702  Indirect
Loxo Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGM:LOXO
(historical quotes, profile, other insiders)
6-Aug-142,175,857  Indirect
Mirati Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqCM:MRTX
(historical quotes, profile, other insiders)
1-Jul-141,167,000  Indirect
Otonomy, Inc.
Beneficial Owner (10% or more)
NasdaqGS:OTIC
(historical quotes, profile, other insiders)
18-Aug-142,256,398  Indirect
Relypsa, Inc.
Beneficial Owner (10% or more)
NasdaqGS:RLYP
(historical quotes, profile, other insiders)
17-Sep-148,857,551  Indirect
Roka Bioscience, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ROKA
(historical quotes, profile, other insiders)
22-Jul-143,190,051  Indirect
RESPONSE BIOMEDICAL
Beneficial Owner (10% or more)
OTC BB:RPBIF
(historical quotes, profile, other insiders)
7-Nov-133,047,927  Indirect
Supernus Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:SUPN
(historical quotes, profile, other insiders)
13-Feb-13817,000  Indirect
Acceleron Pharma Inc.
Other
NasdaqGM:XLRN
(historical quotes, profile, other insiders)
24-Sep-131,540,759  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
17-Sep-14 *49,000RLYP Sale at $25.07 per share.
(Proceeds of $1,228,430)
16-Sep-14 *45,000RLYP Sale at $25.45 - $26.06 per share.
(Proceeds of about $1,159,000)
18-Aug-14 *171,875OTIC Purchase at $16 per share.
(Cost of $2,750,000)
18-Aug-14 *2,084,523OTIC Acquisition (Non Open Market)
15-Aug-14 *990,000RLYP Sale at $26.35 per share.
(Proceeds of $26,086,500)
6-Aug-14 *275,385LOXO Purchase at $13 per share.
(Cost of $3,580,005)
6-Aug-14 *1,900,472LOXO Acquisition (Non Open Market)
22-Jul-14 *2,832,364ROKA Acquisition (Non Open Market)
22-Jul-14 *383,333ROKA Purchase at $12 per share.
(Cost of $4,599,996)
16-Jul-14 *4,688ROKA Statement of Ownership
1-Jul-14 *5,000MRTX Sale at $20.04 per share.
(Proceeds of $100,200)
30-Jun-14 *14,000MRTX Sale at $20.33 - $21.11 per share.
(Proceeds of about $290,000)
27-Jun-14 *88,332MRTX Sale at $21.79 - $23.09 per share.
(Proceeds of about $1,982,000)
20-Nov-13 *712,192RLYP Purchase at $11 per share.
(Cost of $7,834,112)
20-Nov-13 *1,744,711RLYP Option Exercise at $0.17 per share.
(Cost of $296,600)
20-Nov-13 *27,282RLYP Disposition (Non Open Market) at $11 per share.
(Value of $300,102)
20-Nov-13 *7,511,930RLYP Acquisition (Non Open Market)
7-Nov-13 *816,325RPBIF Purchase at $2.45 per share.
(Cost of $1,999,996)
29-Oct-13 *125,000MRTX Purchase at $17.50 per share.
(Cost of $2,187,500)
24-Sep-13 *2,109,642XLRN Acquisition (Non Open Market)
18-Sep-13 *5,825XLRN Statement of Ownership
12-Jul-13 *1,149,332MRTX Statement of Ownership
23-May-13 *12,500AMBI Purchase at $6.99 per share.
(Cost of $87,375)
22-May-13 *21,300AMBI Purchase at $6.86 per share.
(Cost of $146,118)
21-May-13 *776,189AMBI Acquisition (Non Open Market)
21-May-13 *669,871AMBI Purchase at $6.90 - $8 per share.
(Cost of about $4,991,000)
20-May-13 *10,600AMBI Purchase at $6.78 per share.
(Cost of $71,868)
15-May-13 *307AMBI Statement of Ownership
13-Feb-13 *150,000SUPN Sale at $7.58 per share.
(Proceeds of $1,137,000)
12-Feb-13 *152,183SUPN Sale at $7.52 per share.
(Proceeds of $1,144,416)
18-Dec-12 *100,000SUPN Sale at $7.08 per share.
(Proceeds of $708,000)
17-Dec-12 *197,815SUPN Sale at $6.85 per share.
(Proceeds of $1,355,032)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?